GSK vs INSP · P/E 13, $103.31B cap vs P/E 9.4, rev $405.2M
GlaxoSmithKline PLC ADR (GSK) versus Inspire Medical Systems Inc (INSP) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Inspire Medical Systems Inc (INSP) is a medical devices company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported INSP revenue for 2026-06-30 was $405.2M. Net income was -$11.0M. Revenue was up 98.0% from 2026-03-31 to 2026-06-30. INSP currently screens at market cap $1.19B and trailing P/E 9.4.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. INSP currently screens at market cap $1.19B and trailing P/E 9.4.
Not investment advice. Open the GSK and INSP stock pages for the full models.
Not investment advice.